HCA Healthcare
Operator of hospital-anchored care networks spanning inpatient, outpatient, emergency, and physician services.
$417.82
After-hours close−0.02 (−0.00%)
At close$417.84(−0.36%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 102.23%Insiders 0.17%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 216.50M · Float 146.40M · 67.6% free float
Institutions13F, as of Jun 30, 2026
1,395 holders · 221.34M shares · 126 new positions · 568 increased · 575 reduced · 209 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 13.00M | 6.01% | −359.7K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 10.14M | 4.68% | −36.7K | Aug 13, 2026 |
| Sanders Capital, LLC | 8.83M | 4.08% | −128.9K | Aug 10, 2026 |
| State Street Corp | 7.47M | 3.45% | −70.5K | Aug 7, 2026 |
| Wellington Management Group LLP | 4.71M | 2.17% | +799.8K | Aug 14, 2026 |
| Geode Capital Management, LLC | 3.67M | 1.69% | −24.5K | Aug 12, 2026 |
| First Eagle Investment Management, LLC | 3.30M | 1.52% | +41.0K | Aug 24, 2026 |
| Vanguard Portfolio Management LLC | 2.71M | 1.25% | −45.0K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Thomas F. Frist, Jr.incl. William R. Frist, Thomas F. Frist III +3 more | 31.60% | 70.56M | 13D | Feb 10, 2026 ↗ |
| Vanguard Capital Management | 5.25% | 11.75M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Hercules Holding Ii | 10 percent owner | 32.28M | 14.91% | Feb 10, 2026 |
| Samuel N. Hazen | director, officer: CEO | 80.9K | 0.04% | Feb 12, 2026 |
| Mike A. Marks | officer: EVP and CFO | 46.6K | 0.02% | May 11, 2026 |
| Christopher F. Wyatt | officer: SVP & Controller | 44.4K | 0.02% | Feb 12, 2026 |
| Michael S. Cuffe | officer: EVP and Chief Clinical Officer | 32.1K | 0.01% | Feb 12, 2026 |
| Robert J. Dennis | director | 26.6K | 0.01% | May 1, 2025 |
| Jon M. Foster | officer: EVP and COO | 23.1K | 0.01% | Feb 12, 2026 |
| Nancy Ann Deparle | director | 21.9K | 0.01% | Apr 30, 2026 |
| Thomas F. Iii Frist | director, 10 percent owner: | 15.9K | 0.01% | Apr 30, 2026 |
| Wayne Joseph Riley | director | 15.0K | 0.01% | Apr 30, 2026 |
9 ten-percent owners hold 100.64M shares by Form 4, outside the officers-and-directors figure above · 49 people have not refiled in the last 18 months (70.96M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 18, 2026 | Michael R. McAleveyofficer: EVP & Chief Legal & Admin Off. | Sale | 1,694 | $533.37 | 8,853 |
| Feb 11, 2026 | Jennifer Berresofficer: SVP & Chief Human Res. Officer | Sale · 2 lots | 8,020 | $514.58 | 11,993 |
| Feb 11, 2026 | Christopher F. Wyattofficer: SVP & Controller | Sale | 4,000 | $505.00 | 44,379 |
| Feb 3, 2026 | Michael S. Cuffeofficer: EVP and Chief Clinical Officer | Sale | 1,500 | $498.09 | 30,003 |
| Feb 3, 2026 | Samuel N. Hazendirector, officer: CEO | Sale · 7 lots | 42,877 | $501.04 | 32,276 |
| Nov 5, 2025 | Michael R. McAleveyofficer: EVP & Chief Legal & Admin Off. | Sale | 3,892 | $473.79 | 3,487 |
| Sep 8, 2025 | Michael S. Cuffeofficer: EVP and Chief Clinical Officer | Sale | 3,836 | $418.84 | 31,503 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. William R. Keating · MA09 | Purchase | $15,001 – $50,000 | Jun 30, 2026 | Aug 14, 2026 ↗ | |
| Rep. Jared Moskowitz · FL23 | Purchase | $1,001 – $15,000 | Jun 17, 2026 | Jul 27, 2026 ↗ |